DCOY

Decoy Therapeutics
DCOY

5.84 USD
-0.16
2.67%
At close Updated Apr 10, 4:00 PM EDT
Pre-market
After hours
5.81
-0.03
0.51%
1 day
-2.67%
5 days
-1.02%
1 month
-29.3%
3 months
-40.29%
6 months
-88.07%
Year to date
-25.32%
1 year
-94.59%
5 years
-99.99%
10 years
-100%
 

About: Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Employees: 11

Healthcare Biotechnology
0
Funds holding %
of 8,115 funds
Explore Fund Trends
0
Analysts bullish %
of 1 analysts
See Analyst Outlook
0
Positive news %
of 4 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™